The Global Blood Stream Infection Testing Market: 2017-2026 - Set to Record a CAGR of 8.9% - ResearchAndMarkets.com

The "Blood
Stream Infection Testing - Global Market Outlook (2017-2026)"
report has been added to ResearchAndMarkets.com's
offering.

According to this report, the Global Blood Stream Infection Testing
Market is expected to grow at a CAGR of 8.9% during the forecast period.

Some of the factors such as rise in prevalence of infections such as
abdominal infections, dental infections and increase in occurrence
geriatric population are fueling the market growth. However, strict
government rules associated to the safety and efficacy is limiting the
market growth. Blood Stream Infection testing market provides ample
opportunities to ongoing R&D activities in various countries across the
globe.

Amongst end-user, hospital laboratories segment accounted held
significant market share during the forecast period. The healthcare
industry is steadily adopting automated solutions to diminish the cost
incurred on staffing and to produce accurate results. Also, automated
solutions aid healthcare professionals in reducing the time taken for
manually intensive tasks. This allows researchers to focus extensively
on patient consultation and precision in diagnosis and improving
productivity.

By geography, North America dominated the market during the forecast
period due to the factors such as high infection rate, increase in
awareness, high diagnosis rate, favorable medical reimbursement
scenario, and developed medical facilities in this region.

Test Types Covered:

• Conventional Blood Culture Tests
• Blood Gases
• Complete Blood Count (CBC)
• Culture of Skin Sore
• Cerebrospinal Fluid (CSF) Culture
• Platelet Count
• Urine Culture
• Chest X-Ray
• Clotting Studies
• Polymerase Chain Reaction (PCR) Method
• Nucleic Acid Testing
• Mass Spectroscopy
• Point-of-Care Testing

Products Covered:

• Reagents
• Instruments
• Other Products

Technologies Covered:

• Non-Conventional Testing
• Conventional Testing

Applications Covered:

• Mycobacteria
• Fungemia
• Bacteremia

End-users Covered:

• Hospital Laboratories
• Reference Laboratories
• Academic Research Laboratories
• Independent Diagnostic Centers
• Other End-users

Companies Profiled:

• Thermo Fisher Scientific Inc.
• Siemens Healthcare
• F. Hoffmann-La Roche AG
• Danaher
• Cepheid Inc.
• C. R. Bard Inc.
• bioMerieux Inc.
• Becton, Dickinson & Company
• Beckman Coulter Inc.
• Alere Inc.
• Abbott Laboratories

For more information about this report visit https://www.researchandmarkets.com/research/dbjk9k/the_global_blood?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190118005256/en/